1. Home
  2. BMR vs EVAX Comparison

BMR vs EVAX Comparison

Compare BMR & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.38

Market Cap

24.5M

Sector

Technology

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.77

Market Cap

25.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMR
EVAX
Founded
2009
2008
Country
Israel
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
25.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BMR
EVAX
Price
$1.38
$3.77
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.25
AVG Volume (30 Days)
63.7K
★ 101.5K
Earning Date
08-11-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$2.72
52 Week High
$2.88
$6.92

Technical Indicators

Market Signals
Indicator
BMR
EVAX
Relative Strength Index (RSI) 44.14 63.16
Support Level $1.19 $2.90
Resistance Level $1.40 $4.57
Average True Range (ATR) 0.14 0.31
MACD -0.03 0.09
Stochastic Oscillator 3.70 55.90

Price Performance

Historical Comparison
BMR
EVAX

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: